Royalty Pharma recognizes our responsibility to help protect the planet and we are committed to supporting those who are working to improve global environmental sustainability. As part of this purpose, we commit to continuously evaluate the key environmental impacts of our operations and take steps to measure, manage and minimize those impacts.

While Royalty Pharma does not directly conduct biopharma research and development or manufacture or market the biopharmaceutical assets in which we participate, we encourage environmental awareness on the part of our business partners. We believe in taking collective responsibility for our environmental impact.